de
en

Company
Services
Sectors
Transactions
Team
Insights
News
Career
Contact

Cowen advises Gilead Sciences, Inc. on the sale of Spleen Tyrosine Kinase (SYK) Inhibitor Portfolio to Kronos Bio

July 2020

Similar Transactions

Recent Transactions

11. August 2023
TD COWEN ADVISES VALANTIC ON THE EXPANSION OF ITS FINANCING STRUCTURE
13. July 2023
TD Cowen advises DPE Deutsche Private Equity on the acquisition financing for the purchase of atacama software
5. May 2023
TD Cowen advises NORD Holding on the sale of hg medical

Recent News

8. September 2023
TD Cowen advises valantic on the expansion of its financing structure
15. August 2023
ONE TEAM TOGETHER: Our summer events with adrenaline, endurance and sunsets
14. July 2023
TD Cowen advises DPE Deutsche Private Equity on the acquisition financing for the purchase of atacama Software

Subscribe to Newsletter

To subscribe to our Newsletter, please use the following link.

© 2023 TD Cowen Continental Europe

Imprint
Privacy
Contact